Clinical Study of LY011 in the Treatment of Advanced Pancreatic Cancer
NCT04966143
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
UNKNOWN
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Pancreatic Cancer
Interventions
BIOLOGICAL:
LY011
Sponsor
Shanghai Longyao Biotechnology Inc., Ltd.